| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18d92c46f60af8af24e262b67381d7eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_799f7b5ba068c0478db0fbf334e487e9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C239-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C259-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C259-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-38 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C239-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-34 |
| filingDate |
2017-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fdc180a894b1578881a2da4b223eadb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e9a52ff663189b6138020a6bfafd021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d64272f753ede0c9e289c6a6c7301be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_920b5264adbd671ef23145d3732e17e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d6b81c587c09d534938570c910178ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd27a82ae633e57890e4751e32c08245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d98987fb0ff4d23e4f293c6c2b6a2559 |
| publicationDate |
2018-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2018094334-A1 |
| titleOfInvention |
Prodrugs of hydroxamate-based gcpii inhibitors |
| abstract |
Prodrugs of hydroxamate-based GCPII inhibitors and methods of their use for treating a disease or condition are disclosed. |
| priorityDate |
2016-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |